FDA clarifies process for disputing OTC orders in final guidance
Regulatory NewsFerdous Al-Faruque
GuidanceOTCPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsFerdous Al-FaruqueGuidanceOTCPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)